Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders

A Tbakhi1, M Edinger, J Myles

  • 1Department of Clinical Pathology, Cleveland Clinic Foundation, OH 44195, USA.

Cytometry
|October 1, 1996
PubMed

Insights

Non-Hodgkin's lymphomas (NHL) are immune system cancers. Multicolor flow cytometry aids in diagnosing specific NHLs and related disorders, though its role in lymph node biopsy evaluation lacks consensus.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Non-Hodgkin's lymphomas (NHL) are recognized as neoplasms of the immune system.
  • Extensive research has elucidated the immunophenotypic and functional aspects of neoplastic lymphocytes.
  • A lack of consensus exists regarding the precise utility of immunotypic and genotypic ancillary procedures in lymph node biopsy analysis.

Purpose of the Study:

  • To review the existing literature on the role of ancillary procedures in NHL diagnosis.
  • To provide an overview of multicolor flow cytometry's application in diagnosing NHL and related conditions.

Main Methods:

  • Literature review of selected studies.
  • Overview of multicolor flow cytometry techniques.

Main Results:

  • Significant advancements in understanding neoplastic lymphocytes have been made over two decades.
  • Multicolor flow cytometry is a valuable tool for diagnosing specific NHL subtypes and related disorders.

Conclusions:

  • Despite progress, the exact role of immunotypic and genotypic tests in lymph node biopsies remains debated.
  • Multicolor flow cytometry offers a crucial method for accurate NHL diagnosis and classification.